|
SNIP1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.616400E-02 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.178400E-02 |
| Normal-vs-Stage2 |
4.086100E-02 |
| Normal-vs-Stage3 |
5.773600E-02 |
| Normal-vs-Stage4 |
1.121370E-03 |
| Stage1-vs-Stage2 |
5.587400E-01 |
| Stage1-vs-Stage3 |
5.690000E-01 |
| Stage1-vs-Stage4 |
1.008810E-01 |
| Stage2-vs-Stage3 |
9.238400E-01 |
| Stage2-vs-Stage4 |
3.244600E-01 |
| Stage3-vs-Stage4 |
4.878400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.832000E-02 |
| Normal-vs-AfricanAmerican |
3.957700E-02 |
| Normal-vs-Asian |
4.658000E-03 |
| Caucasian-vs-AfricanAmerican |
7.524800E-01 |
| Caucasian-vs-Asian |
3.633200E-01 |
| AfricanAmerican-vs-Asian |
3.504600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.678500E-03 |
| Normal-vs-Female |
4.731600E-01 |
| Male-vs-Female |
2.093400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
7.870100E-02 |
| Normal-vs-Extreme_Weight |
3.225800E-02 |
| Normal-vs-Obese |
8.866000E-02 |
| Normal-vs-Extreme_Obese |
3.271700E-02 |
| Normal_Weight-vs-Extreme_Weight |
9.108800E-01 |
| Normal_Weight-vs-Obese |
6.600800E-01 |
| Normal_Weight-vs-Extreme_Obese |
8.175400E-01 |
| Extreme_Weight-vs-Obese |
7.027400E-01 |
| Extreme_Weight-vs-Extreme_Obese |
7.544400E-01 |
| Obese-vs-Extreme_Obese |
5.696800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.233000E-01 |
| Normal-vs-Age(41-60Yrs) |
3.963800E-01 |
| Normal-vs-Age(61-80Yrs) |
2.095100E-03 |
| Normal-vs-Age(81-100Yrs) |
1.827850E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.976600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.067800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.327800E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.107900E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.665900E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.003000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
2.358200E-01 |
| Normal-VS-Type2 PRCC |
2.233600E-04 |
| Normal-VS-KIRP CIMP |
3.095600E-01 |
| Normal-VS-Unclassified PRCC |
4.635800E-01 |
| Type1 PRCC-VS-Type2 PRCC |
6.977400E-03 |
| Type1 PRCC-VS-KIRP CIMP |
6.853000E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
9.951000E-01 |
| Type2 PRCC-VS-KIRP CIMP |
4.063200E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
4.848100E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
6.843800E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
8.70219999948851E-07 |
| Normal-vs-N1 |
3.625600E-01 |
| Normal-vs-N2 |
2.233900E-02 |
| N0-vs-N1 |
5.317700E-02 |
| N0-vs-N2 |
9.967200E-01 |
| N1-vs-N2 |
4.062400E-01 |
|
|
